Inclusion body myositis: Clinical and pathological boundaries

Annals of Neurology

Volumn 40, Issue 4, 1996, Pages 581-586

  Amato, Anthony A ^a,b   Gronseth, Gary S ^a   Jackson, Carlayne E ^b   Wolfe, Gil I ^c   Katz, Jon S ^c   Bryan, Wilson W ^c   Barohn, Richard J ^c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE;

ADULT; AGED; ARTICLE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DRUG RESISTANCE; EXTENSOR MUSCLE; FEMALE; FLEXOR MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; PERIPHERAL NEUROPATHY; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AZATHIOPRINE; BIOPSY; CREATINE KINASE; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029957253     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400407     Document Type: Article

References (22)

1. Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 1991;325:1487-1498
2. Griggs RC, Mendell JR, Miller RC. Inflammatory myopathies. In: Evaluation and treatment of myopathies. Philadelphia: FA Davis, 1995:154-210
3. Lotz BP, Engel AG, Nishino H, et al. Inclusion body myositis. Observations in 40 patients. Brain 1989;112:727-747
4. Kissel JT, Mendell JR, Rammodan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:331-334
5. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990;27:343-356
6. Kissel JT, Halterman RK, Rammodan KW, Mendell JR. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991;48:26-30
7. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16:193-208
8. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209-215
9. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neural 1991:48:1229-1234
10. Leff RL, Miller FW, Hicks J, et al. The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine 1993;72:225-235
11. Soueidan SA, Dalakas MC. Treatment of inclusion body myositis with high-dose intravenous immunoglobulin. Neurology 1993;43:876-879
12. Joffe MM, Love LA, Leff RL. Drug therapy of idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993:94:379-387
13. Amato AA, Barohn RJ, Jackson CE, et al. Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology 1994:44:1516-1518
14. Barohn RJ, Amato AA, Sahenk Z, et al. Inclusion body myositis: explanation for poor response to therapy. Neurology 1995;45:1302-1304
15. Tymms KE, Webb J. Dermatomyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985;12:1140-1148
16. Medical Research Council. Aids to the examination of the peripheral nervous system. London: Baillière Tindall, 1986
17. Askanas V, Engel WK, Alvarez RB. Enhanced detection of Congo-red-positive deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence techniques. Neurology 1993;43:1265-1267
18. Mendell JR, Florence J. Manual muscle testing. Muscle Nerve 1990;13(suppl):S16-S20
19. Amato AA, Gronseth GS, Callerame KJ, et al. Tomaculous neuropathy: a clinical and electrophysiologic study in patients with and without 1.5 Mb deletions in chromosome 17p11.2. Muscle Nerve 1996;19:16-22
20. Griggs RC, Askanas VA, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995:38:705-713
21. Joy JL, Oh SSJ, Baysal AI. Electrophysiological spectrum of inclusion body myositis. Muscle Nerve 1990;13:949-951
22. Eisen A, Berry K, Gibson G. Inclusion body myositis (IBM): myopathy or neuropathy? Neurology 1983:33:1109-1114